ABG-WTT Global Life Science Capital Partners GP Ltd — Q2 2025 13F-HR

← ABG-WTT Global Life Science Capital Partners GP Ltd

Q2 2025 · 13F-HR

ABG-WTT Global Life Science Capital Partners GP Ltdholdings as filed

Filed 2025-08-14 · accession 0000950123-25-008425

$26.8M

Reported value

Positions

2025-06-30

Period end

View analyzed profile →PRO

The Brief · ABG-WTT Global Life Science Capital Partners GP Ltd · Q2 2025

AI · grounded in 13F

ABG-WTT Global Life Science Capital Partners GP Ltd established a new position in CBLL valued at $20.38M. The fund also initiated a new position in RPID worth $6.38M. These two holdings comprise the fund's total assets under management of $26.76M.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
15678C102	CBLL	CERIBELL INC	$20.4M	76.2%	1,088,101	Common	SOLE
75340L104	RPID	RAPID MICRO BIOSYSTEMS INC	$6.4M	23.8%	1,848,296	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.